share_log

Recap: Aptose Biosciences Q4 Earnings

Recap: Aptose Biosciences Q4 Earnings

回顧:Aptose Biosciences第四季度收益
Benzinga ·  03/27 04:10

Aptose Biosciences (NASDAQ:APTO) reported its Q4 earnings results on Tuesday, March 26, 2024 at 04:02 PM.

Aptose Biosciences(納斯達克股票代碼:APTO)於2024年3月26日星期二下午4點02分公佈了其第四季度業績。

Here's what investors need to know about the announcement.

以下是投資者需要了解的有關該公告的信息。

Earnings

收益

Aptose Biosciences beat estimated earnings by 9.0%, reporting an EPS of $-1.44 versus an estimate of $-1.59.

Aptose Biosciences的收益比預期高出9.0%,每股收益爲-1.44美元,而估計爲-1.59美元。

Revenue was down $0 from the same period last year.

收入比去年同期下降了0美元。

Past Earnings Performance

過去的收益表現

Last quarter the company beat on EPS by $0.29 which was followed by a 24.0% drop in the share price the next day.

上個季度,該公司的每股收益高出0.29美元,隨後第二天股價下跌了24.0%。

To track all earnings releases for Aptose Biosciences visit their earnings calendar here.

要追蹤Aptose Biosciences的所有業績,請在此處訪問其業績日曆。

This article was generated by Benzinga's automated content engine and reviewed by an editor.

本文由Benzinga的自動內容引擎生成,並由編輯審閱。

譯文內容由第三人軟體翻譯。


以上內容僅用作資訊或教育之目的,不構成與富途相關的任何投資建議。富途竭力但無法保證上述全部內容的真實性、準確性和原創性。
    搶先評論